Timely reports on clinical research, legislative updates and product launches, from the editors of Review of Optometry and RCCL. Stories post each weekday morning.
Those with no prior history of the inflammatory condition were not affected. Relevant risk factors for new relapses included female sex and rheumatic autoimmune disease.
Extending the time between scans allows the slower blood flow in this region to be imaged, which could potentially help distinguish diseased eyes earlier.
The impact is not restricted to high myopes, who made up only half of predicted cases. Researchers suggest more aggressive intervention is needed to abate the disease’s imminent public health burden.
Called targeted mean total deviation, the metric could better detect changes in early to moderate forms of the condition through heightened sensitivity and faster rate of change over other indices.
Subretinal injection of voretigene neparvovec achieved stable median BCVA and mean retinal thickness, and improvements in low-level luminance VA up to 32 months, but new chorioretinal atrophy appeared in 50% of treated eyes.
A survey found that frequency and severity were lower among those who only used one modality and highest in those who used both. However, the study didn’t account for confounding lifestyle factors like digital device use.
Three different power levels all demonstrated efficacy; nevertheless, the treatment’s long-term safety and the possibility of any potential rebound effects remain to be explored.
Nine of 11 studies in a new literature review reported that the treatment’s clinical benefit was superior to conventional methods, but industry involvement should give pause.